This study began in January, 1960, as a doubleblind controlled therapeutic trial to determine the short-term value of metronidazole (Flagyl) in symptomatic trichomoniasis of women; 3 months later, when the results were analysed and found to be excellent, it was decided to continue the investigation and to arrive at a long-term assessment of the drug.
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Material and Results
The patients were seen at the V.D. Clinic of the Central Middlesex Hospital. Prostitutes and women known to be very promiscuous were excluded from the trial as it was thought that the re-infection rate might make the interpretation of results difficult. Flagyl (200 mg. three times daily for 10 days) and dummy tablets were dispensed in identical packets which were randomized and numbered. The key to the numbers was kept by the hospital pharmacist until the end of the trial 3 months later. In cases of treatment failure, the patient was given a 10-day course of Flagyl; this ensured that all who failed to respond had at least one course of the drug.
In this controlled part of the trial, there were 67 women, 10 of whom defaulted after their first attendance; of the remaining 57 patients, 28 had received Flagyl and 29 a course of dummy tablets. It was of interest to find that of the ten early defaulters, seven had received dummy tablets, which suggests in the light of the trial results that early defaulting does not necessarily indicate successful treatment. When it was decided to continue the study, controls were omitted and Flagyl was given for 7 days only. In cases of treatment failure, a second 7-day course of Flagyl was prescribed. A further 55 patients, 21 of whom were pregnant, were treated and a determined effort was made to keep in touch with them as well as the first group as long as possible. Of the 55 patients, eleven defaulted almost immediately; of the rest, including the first group of cases, the majority could be re-examined a year after the start of treatment. There were seven recurrences in the 44 patients observed, but three responded satisfactorily to a second course of Flagyl. 258 
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The consolidated results of the two groups of patients are given in Table III . Of the 21 pregnant women, twenty were observed for from one month to one year after treatment and seventeen responded promptly to treatment. Seven of the infants born to these women were examined in due course and no abnormality was apparent. It is proposed to extend this part of the study in the future. Among the 101 patients followed for a reasonable period there were eleven treatment failures; four responded to a second course of Flagyl, five did not, and the remaining two had only a single course ofthe drug. The possibility of re-infection was admitted by seven patients classified as treatment failures but for various reasons the consorts of these women could not be examined and this added to our uncertainty whether any of them had a re-infection rather than a relapse. In three patients active trichomonads were found at the end of treatment and these are clearly treatment failures.
The result as a whole is gratifying with 92 per cent. seemingly cured. Experience suggests that, in patients who fail after the standard 7-day course of Flagyl, it is worth repeating the drug before resorting to other measures. The fact that a few primary treatment failures did occur in this series might be due to poor absorption of the compound, as shown by Kane, McFadzean, and Squires (1961) , or to the existence or development of Flagyl-resistant Trichomonas vaginalis, as found by Robinson (1962) .
Eight patients complained of a bitter taste in the mouth, epigastric discomfort, and sometimes nausea whilst taking Flagyl, but it was not necessary to discontinue the -drug. No side-effects were complained of by those taking dummy tablets. As Flagyl is a nitro-derivative, special attention was paid during the controlled trial to the blood picture, and total and differential white blood counts were carried out before and after treatment in forty patients, eighteen of whom were on dummy tablets and 22 on Flagyl. There was a fall in total and polymorphonuclear neutrophils in six of the control group and twelve of the drug-treated patients. This fall was of a minor degree except in two of the cases receiving Flagyl where the polymorphonuclear neutrophil count fell from 4,500 and 6,000/cmm. before treatment to 1,500/cmm. after treatment in both cases. The counts recovered their pre-treatment level a week later and there were no clinical symptoms associated with the fall, but clearly one must remain watchful for the possibility of more serious bone-marrow depression.
The incidence of fungi seen on direct microscopy of vaginal secretions before and after treatment with Flagyl is shown in Table IV . There is a significant increase in fungi after successful treatment of trichomonal vaginitis with Flagyl though some of these cases remained asymptomatic. The increase may be more apparent than real because of the unmasking of fungi when T. vaginalis was no longer present. As only one out of ten cases treated with Flagyl had some vaginitis afterwards which could have been due to fungi, prophylactic therapy against fungi when administering Flagyl is not advocated. 
